Regeneron Pharmaceuticals Inc (OQ:REGN)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for REGN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 25th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 15/19 May 15/19 Goldstein Joseph L Direct Ownership Common Stock S - Open market or private sale -1,000 $305.93
May 15/19 May 14/19 Stahl Neil Direct Ownership Common Stock S - Open market or private sale -3,278 $306.37
May 15/19 May 14/19 Stahl Neil Direct Ownership Common Stock S - Open market or private sale -6,575 $305.43
May 15/19 May 13/19 Stahl Neil Direct Ownership Non-Qualified Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -25,000  
May 15/19 May 13/19 Stahl Neil Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -15,147 $304.20
May 15/19 May 13/19 Stahl Neil Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 25,000 $52.03
Apr 18/19 Apr 18/19 Fenimore Christopher R. Direct Ownership Incentive Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -350  
Apr 18/19 Apr 18/19 Fenimore Christopher R. Indirect Ownership Common Stock G - Gift 350  
Apr 18/19 Apr 18/19 Fenimore Christopher R. Direct Ownership Common Stock G - Gift -350  
Apr 18/19 Apr 18/19 Fenimore Christopher R. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 350 $21.25
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for REGN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 25th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 15/19 May 15/19 Goldstein Joseph L Direct Ownership Common Stock S - Open market or private sale -1,000 $305.93
May 15/19 May 13/19 Stahl Neil Direct Ownership Non-Qualified Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -25,000  
May 15/19 May 14/19 Stahl Neil Direct Ownership Common Stock S - Open market or private sale -3,278 $306.37
May 15/19 May 14/19 Stahl Neil Direct Ownership Common Stock S - Open market or private sale -6,575 $305.43
May 15/19 May 13/19 Stahl Neil Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -15,147 $304.20
May 15/19 May 13/19 Stahl Neil Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 25,000 $52.03
Apr 18/19 Apr 18/19 Fenimore Christopher R. Direct Ownership Incentive Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -350  
Apr 18/19 Apr 18/19 Fenimore Christopher R. Indirect Ownership Common Stock G - Gift 350  
Apr 18/19 Apr 18/19 Fenimore Christopher R. Direct Ownership Common Stock G - Gift -350  
Apr 18/19 Apr 18/19 Fenimore Christopher R. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 350 $21.25
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $REGN

StockTwits